M&A Deal Summary

Cycle Pharmaceuticals Acquires Applied Therapeutics

On December 11, 2025, Cycle Pharmaceuticals acquired life science company Applied Therapeutics

Acquisition Highlights
  • This is Cycle Pharmaceuticals’ 2nd transaction in the Life Science sector.
  • This is Cycle Pharmaceuticals’ 2nd transaction in the United States.
  • This is Cycle Pharmaceuticals’ 1st transaction in New York.

M&A Deal Summary

Date 2025-12-11
Target Applied Therapeutics
Sector Life Science
Buyer(s) Cycle Pharmaceuticals
Deal Type Add-on Acquisition

Target

Applied Therapeutics

New York, New York, United States
Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied Therapeutics is based in New York, New York.

Search 214,876 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Cycle Pharmaceuticals

Cambridge, United Kingdom

Category Company
Founded 2012
Sector Life Science
DESCRIPTION

Cycle Pharmaceuticals is a developer of rare disease therapies focuses on rare metabolic, immunological, and neurological genetic conditions. Cycle Pharmaceuticals was founded in 2012 and is based in Cambridge, United Kingdom.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: New York M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-14 Vanda Pharmaceuticals

Washington, District of Columbia, United States

Vanda Pharmaceuticals is a bio pharmaceutical company focused on the development and commercialization of innovative therapies. Vanda Pharmaceuticals is based in Washington, District of Columbia.

Buy -